Logotype for ICU Medical Inc

ICU Medical (ICUI) Q4 2015 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for ICU Medical Inc

Q4 2015 earnings summary

6 Nov, 2026

Executive summary

  • FY15 described as a record year for revenue, gross margin and adjusted EBITDA; direct-business growth, cost improvements and investment aimed to diversify revenue and profits from a concentrated customer.

  • Priorities included new product launches, global revenue growth and disciplined capital deployment; management expected substantially improved earnings and cash flow in 2016.

Financial highlights

  • Revenue was $341.7M vs. $309.3M in 2014; constant-currency revenue was $350.6M, up $41.3M YoY.

  • Net income rose to $45.0M from $26.3M; diluted EPS was $2.73 vs. $1.68.

  • Operating income was $68.6M vs. $39.0M; operating cash flow was $54.9M vs. $60.6M.

  • Fourth-quarter revenue was $90.4M, gross profit $48.3M, net income $5.5M and diluted EPS $0.33.

Outlook and guidance

  • Management expected substantially improved earnings and cash flow in 2016; the largest customer was expected to represent a record-low share of revenue, though exposure remained significant.

  • 2016 capital expenditures estimated at $18M–$20M for US and Mexico manufacturing equipment, molds, IT and Mexico facility expansion.

  • Slovakia facility closure and product transfer to Mexico expected to finish in H2 2016; the board expected closure completion in Q3 2016.

  • SwabCap expected to have minimal EPS impact in its first year, with a greater return on invested capital thereafter.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from ICU Medical